Cellbxhealth (LON:CLBX) Posts Quarterly Earnings Results

Cellbxhealth (LON:CLBX) posted its quarterly earnings data on Wednesday. The company reported GBX (0.24) EPS for the quarter, Digital Look Earnings reports.

Cellbxhealth Stock Down 4.9%

CLBX traded down GBX 0.07 during midday trading on Wednesday, reaching GBX 1.33. 900,639 shares of the company’s stock were exchanged, compared to its average volume of 4,237,635. Cellbxhealth has a one year low of GBX 0.85 and a one year high of GBX 2.70. The stock has a market cap of £15.13 million and a price-to-earnings ratio of -0.24.

Cellbxhealth Company Profile

CelLBxHealth plc is a precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis – including whole-cell imaging, proteomic profiling and full genomic workflows.
Commercial activities centre on (1) Product Sales: Accelerating Parsortix platform adoption and consumable sales through CROs and clinical lab partnerships.